Related Experiment Videos
Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies
R Schaffel1, M Nucci, R Portugal
1Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Brazil.
Abstract:
A total of 21 patients with hematologic malignancies were given thiabendazole for treatment of strongyloidiasis. Fifteen patients were cured. Since there were no relapses, it is unlikely that maintenance therapy has a role in the management of strongyloidiasis in this population of patients.